Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
HIV infection results in CD4+ T cell deficiency, but efficient combination antiretroviral therapy (c-ART) restores T cells and decreases morbidity and mortality. However, immune restoration by c-ART remains variable, and prolonged T cell deficiency remains in a substantial proportion of patients. In a prospective open-label phase I/IIa trial, we evaluated the safety and efficacy of administration of the T cell regulator IL-7. The trial included 13 c-ART-treated HIV-infected patients whose CD4+ cell counts were between 100 and 400 cells/microl and plasma HIV RNA levels were less than 50 copies/ml. Patients received a total of 8 subcutaneous injections of 2 different doses of recombinant human IL-7 (rhIL-7; 3 or 10 microg/kg) 3 times per week over a 16-day period. rhIL-7 was well tolerated and induced a sustained increase of naive and central memory CD4+ and CD8+ T cells. In the highest dose group, 4 patients experienced transient increases in viral replication. However, functional assays showed that the expanded T cells responded to HIV antigen by producing IFN-gamma and/or IL-2. In conclusion, in lymphopenic HIV-infected patients, rhIL-7 therapy induced substantial functional and quantitative changes in T cells for 48 weeks. Therefore, patients may benefit from intermittent therapy with IL-7 in combination with c-ART.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J. E., Balfour, H. H., Deyton, L. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371101 · Cited by 2,640
CD4+ Count–Guided Interruption of Antiretroviral Treatment
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,231
Changes in thymic function with age and during the treatment of HIV infection
Douek, D. C., McFarland, R. D., Keiser, P. H., Gage, E. A., Massey, J. M., Haynes, B. F., Polis, M. A., Haase, A. T., Feinberg, M. B., Sullivan#, J. L., et al. (1998) · Nature · doi:10.1038/25374 · Cited by 1,893
Kaech, S. M., Tan, J. T., Wherry, E. J., Konieczny, B. T., Surh, C. D., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni1009 · Cited by 1,830
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo
Schluns, K. S., Kieper, W. C., Jameson, S. C., & Lefrançois, L. (2000) · Nature Immunology · doi:10.1038/80868 · Cited by 1,618
Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.
von Freeden-Jeffry, U., Vieira, P., Lucian, L. A., McNeil, T., Burdach, S. E., & Murray, R. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1519 · Cited by 1,428
Changing patterns of mortality across Europe in patients infected with HIV-1
Mocroft, A., Vella, S., Benfield, T., Chiesi, A., Miller, V, Gargalianos, P., Monforte, A. D., Yust, I., Bruun, J., Phillips, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03201-2 · Cited by 1,270
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus: The D:A:D Study
(2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1632 · Cited by 1,113
Cited by
The end of AIDS: HIV infection as a chronic disease
Deeks, S. G., Lewin, S. R., & Havlir, D. V. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61809-7 · Cited by 2,063
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Boomer, J. S., To, K., Chang, K. C., Takasu, O., Osborne, D. F., Walton, A. H., Bricker, T. L., Jarman, S. D., Kreisel, D., Krupnick, A. S., et al. (2011) · JAMA · doi:10.1001/jama.2011.1829 · Cited by 1,781
CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions
Hashimoto, M., Kamphorst, A. O., Im, S. J., Kissick, H. T., Pillai, R. N., Ramalingam, S. S., Araki, K., & Ahmed, R. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-012017-043208 · Cited by 656
Harnessing the biology of IL-7 for therapeutic application
Mackall, C. L., Fry, T. J., & Gress, R. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2970 · Cited by 571
Towards an HIV cure: a global scientific strategy
The International AIDS Society Scientific Working Group on HIV Cure (2012) · Nature Reviews Immunology · doi:10.1038/nri3262 · Cited by 554
Pathogenic Mechanisms of HIV Disease
Moir, S., Chun, T.-W., & Fauci, A. S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130254 · Cited by 463
Interleukin-2 Therapy in Patients with HIV Infection
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903175 · Cited by 381
Yang, X., Su, B., Zhang, X., Liu, Y., Wu, H., & Zhang, T. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mr1019-189r · Cited by 341
Ménétrier-Caux, C., Ray-Coquard, I., Blay, J.-Y., & Caux, C. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0549-5 · Cited by 339
HIV-1 transcription and latency: an update
Van Lint, C., Bouchat, S., & Marcello, A. (2013) · Retrovirology · doi:10.1186/1742-4690-10-67 · Cited by 338
T cell exhaustion during persistent viral infections
Kahan, S. M., Wherry, E. J., & Zajac, A. J. (2015) · Virology · doi:10.1016/j.virol.2014.12.033 · Cited by 324
IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis
Unsinger, J., McGlynn, M., Kasten, K. R., Hoekzema, A. S., Watanabe, E., Muenzer, J. T., McDonough, J. S., Tschoep, J., Ferguson, T. A., McDunn, J. E., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903151 · Cited by 312
Self-citationIL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology
Pellegrini, M., Calzascia, T., Toe, J. G., Preston, S. P., Lin, A. E., Elford, A. R., Shahinian, A., Lang, P. A., Lang, K. S., Morre, M., et al. (2011) · Cell · doi:10.1016/j.cell.2011.01.011 · Cited by 310
Self-citationCumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections
Zeng, M., Smith, A. J., Wietgrefe, S. W., Southern, P. J., Schacker, T. W., Reilly, C. S., Estes, J. D., Burton, G. F., Silvestri, G., Lifson, J. D., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45157 · Cited by 309
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
Katlama, C., Deeks, S. G., Autran, B., Martinez-Picado, J., van Lunzen, J., Rouzioux, C., Miller, M., Vella, S., Schmitz, J. E., Ahlers, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60104-x · Cited by 295
Self-citationEvidence of premature immune aging in patients thymectomized during early childhood
Sauce, D., Larsen, M., Fastenackels, S., Duperrier, A., Keller, M., Grubeck-Loebenstein, B., Ferrand, C., Debré, P., Sidi, D., & Appay, V. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39269 · Cited by 278
“Indeed, recent studies show that administration of rhIL-7 increases in vivo TCR repertoire diversity through the preferential expansion of naive T cells in healthy individuals (51) as well as in lymphopenic HIV-infected patients (52, 53).”
BackgroundCurrent status and challenges of antiretroviral research and therapy
Esté, J. A., & Cihlar, T. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.007 · Cited by 277
Interleukin-7 promotes HIV persistence during antiretroviral therapy
Vandergeeten, C., Fromentin, R., DaFonseca, S., Lawani, M. B., Sereti, I., Lederman, M. M., Ramgopal, M., Routy, J.-P., Sékaly, R.-P., & Chomont, N. (2013) · Blood · doi:10.1182/blood-2012-11-465625 · Cited by 249
“The administration of IL-7 to virally suppressed subjects restores a T-cell homeostatic equilibrium not always achieved by the control of viral load alone under ART.(9,10) IL-7 therapy leads to a significant increase in the absolute number of CD4(1) T cells as a result of increased T-cell cycling and survival and, to…”
BackgroundInfluentialLévy, Y., Sereti, I., Tambussi, G., Routy, J. P., Lelièvre, J. D., Delfraissy, J. F., Molina, J. M., Fischl, M., Goujard, C., Rodriguez, B., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis383 · Cited by 240
Self-citationTotal HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications
Avettand-Fènoël, V., Hocqueloux, L., Ghosn, J., Cheret, A., Frange, P., Melard, A., Viard, J.-P., & Rouzioux, C. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00015-16 · Cited by 208
Self-citationGaardbo, J. C., Hartling, H. J., Gerstoft, J., & Nielsen, S. D. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/670957 · Cited by 180
“Subcutaneous administration of single dose of rhIL-7 (3–100 μg/kg) [174] as well as intermittent doses (3 or 10 μg/kg) [175] results in significant dose-dependent increase in CD4+ cell counts.”
BackgroundAppay, V., Fastenackels, S., Katlama, C., Ait-Mohand, H., Schneider, L., Guihot, A., Keller, M., Grubeck-Loebenstein, B., Simon, A., Lambotte, O., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834640e6 · Cited by 167
“Of note, the use of IL-7, a potent homeostatic regulator and thymopoiesis inducer, may be particularly relevant in this context, since studies performed in humans have shown that its administration resulted in a replenishment of the naive T-cell pool [37–39].”
BackgroundImmune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs
Wilson, E. M. P., & Sereti, I. (2013) · Immunological Reviews · doi:10.1111/imr.12064 · Cited by 167
“An alternative candidate common c chain cytokine, IL-7, which prevents apoptosis of T cells and is required for naive T-cell survival in vivo, has been shown to be well tolerated (119) and to increase CD4 T-cell counts in treated HIV patients (120).”
BackgroundValidation of a gene expression-based subclassification strategy for pediatric septic shock*
Wong, H. R., Cvijanovich, N. Z., Allen, G. L., Thomas, N. J., Freishtat, R. J., Anas, N., Meyer, K., Checchia, P. A., Lin, R., Shanley, T. P., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182257675 · Cited by 164
“with Gram-positive bacteria (%) 23 (23) 24 (29) .”
Influential
Metadata
- Authors
- Levy, Y., Lacabaratz, C., Weiss, L., Viard, J.-P., Goujard, C., Lelièvre, J.-D., Boué, F., Molina, J.-M., Rouzioux, C., Avettand-Fénoêl, V., Croughs, T., Beq, S., Thiébaut, R., Chêne, G., Morre, M., & Delfraissy, J.-F.
- Venue
- Journal of Clinical Investigation
- Published
- 2009-03-16
- Volume
- 119
- Issue
- 4
- Pages
- 997-1007
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2171907379
- Cited by
- 381
- References
- 55
- FWCI
- 16.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.